Latham & Watkins has guided Redwood City, California-based Coherus BioSciences in connection with the divestment of its ophthalmology franchise CIMERLI to generic pharmaceutical and biosimilars company Sandoz Group AG for $170 million. The Latham & Watkins corporate deal team was led by Bay Area-based partners Josh Dubofsky, Jekkie Kim, Ben Potter and Phillip Stoup. Counsel information for Sandoz Group, which is based in Basel, Switzerland, was not immediately available.
Biotech & Pharmaceuticals
January 23, 2024, 9:33 AM